T1	Participants 489 662	Children aged 5-15 years (without prior use of montelukast) with acute moderate to severe asthma exacerbation, as defined using Modified Pulmonary Index Score (MPIS) > or =9
T2	Participants 1069 1131	117 children (60 in montelukast group and 57 in placebo group)
T3	Participants 397 478	Setting Emergency room/outpatient paediatric services of a tertiary care hospital
